Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T21:26:22.245Z.
Calculation as of: 2026-10-06T21:26:22.245Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d0cade57d6bc8828dc71ac364ddc44a4328d7c948fb2699a56d4eea8e3f6e5b7
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Alpha Tau Medical Ltd
Market Cap
$1.31B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.33B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.34B
Operating Cash Flow Yield
N/A
TTM Avg
45.43%
3Y Avg
45.23%
5Y Avg
45.23%
Market Cap
$1.37B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.24B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.23B
Operating Cash Flow Yield
1.92%
TTM Avg
2.00%
3Y Avg
2.00%
5Y Avg
2.00%
Market Cap
$1.23B
Operating Cash Flow Yield
4.90%
TTM Avg
3.02%
3Y Avg
2.54%
5Y Avg
2.54%
Market Cap
$1.39B
Operating Cash Flow Yield
3.84%
TTM Avg
4.59%
3Y Avg
4.10%
5Y Avg
4.07%
Market Cap
$1.22B
Operating Cash Flow Yield
5.30%
TTM Avg
4.74%
3Y Avg
4.15%
5Y Avg
3.70%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Tau Medical Ltd (DRTS) | $1.31B | N/A | N/A | N/A | N/A |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.33B | N/A | N/A | N/A | N/A |
| Omeros Corporation (OMER)vs › | $1.34B | N/A | 45.43% | 45.23% | 45.23% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.37B | N/A | N/A | N/A | N/A |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | N/A | N/A | N/A | N/A |
| Omada Health (OMDA)vs › | $1.23B | 1.92% | 2.00% | 2.00% | 2.00% |
| Cronos Group Inc. (CRON)vs › | $1.23B | 4.90% | 3.02% | 2.54% | 2.54% |
| The Pennant Group, Inc. (PNTG)vs › | $1.39B | 3.84% | 4.59% | 4.10% | 4.07% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 5.30% | 4.74% | 4.15% | 3.70% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.40B | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
